SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-10-08 09:22
Tx date 2024-09-30 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,749
+19,583 vol
$0.60 each 		71,293
Filed 2023-06-25 23:16
Tx date 2023-06-20 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,750
+18,077 vol
$0.65 each 		51,710
Filed 2022-05-19 22:01
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-17 12:57
Tx date 2022-05-13 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+16,096 vol 		33,633
Filed 2022-04-03 21:21
Tx date 2022-03-29 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-44,368 vol 		117,658
Filed 2021-12-28 11:40
Tx date 2021-12-22 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+17,537 vol 		17,537
Filed 2021-12-28 11:38
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-22 11:30
Tx date 2021-12-21 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
38 - Redemption, retraction, cancellation, repurchase
-44,368 vol 		275,103
Filed 2021-08-26 15:31
Tx date 2021-08-16 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-10,623.7472
-8,812 vol
$1.21 each 		162,026
Filed 2021-08-17 08:35
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-8,812 vol 		319,471
Filed 2021-05-21 12:14
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2020-08-21 21:36
Tx date 2020-08-17 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$6,000
+10,000 vol
$0.60 each 		170,838
Filed 2020-06-17 15:52
Tx date 2020-06-17 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-16,608 vol 		160,838
Filed 2020-06-16 16:06
Tx date 2020-06-16 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-16,608 vol 		328,283
Filed 2020-05-14 13:58
Tx date 2020-05-13 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		344,891
Filed 2019-08-19 15:30
Tx date 2019-08-19 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		337,891
Filed 2019-05-25 14:49
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		177,446
Filed 2019-05-24 12:09
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 12:09
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		177,446
Filed 2019-01-08
Tx date 2019-01-04 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		167,446
Filed 2019-01-03
Tx date 2019-01-03 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
-17,195 vol 		0
Filed 2019-01-03
Tx date 2019-01-03 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
-17,195 vol 		0
Filed 2018-04-06
Tx date 2018-04-03 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		157,446
Filed 2018-03-29
Tx date 2017-11-07 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol 		323,891
Filed 2018-03-29
Tx date 2017-12-06 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol
Filed 2018-03-29
Tx date 2017-11-07 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol 		147,446
Filed 2018-03-29
Tx date 2017-12-06 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol
Filed 2018-03-29
Tx date 2017-12-06 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol
Filed 2018-03-28
Tx date 2018-03-28 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		330,891
Filed 2018-03-16
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Holder: Spousal TFSA (Control or Direction)
Common Shares
57 - Exercise of rights 		$4,000
+7,548 vol
$0.53 each 		7,548
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights 		$-40,000.16
-75,472 vol
$0.53 each 		0
Filed 2018-03-16
Tx date 2018-02-16 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights
+75,472 vol 		75,472
Filed 2018-03-16
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Holder: TFSA (Indirect Ownership)
Common Shares
57 - Exercise of rights 		$15,999
+30,188 vol
$0.53 each 		30,188
Filed 2018-03-13
Tx date 2018-03-13 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-473 vol 		155,313
Filed 2018-03-13
Tx date 2004-09-21 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-13
Tx date 2018-03-13 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership
+473 vol 		473
Filed 2018-01-03
Tx date 2018-01-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash 		$-82,080.80
-22,184 vol
$3.70 each 		17,195
Filed 2018-01-03
Tx date 2018-01-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
-17,193 vol 		39,379
Filed 2018-01-03
Tx date 2018-01-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
-39,377 vol 		17,195
Filed 2017-12-08
Tx date 2017-12-06 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol 		147,446
Filed 2017-12-06
Tx date 2017-12-06 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-53,846 vol 		323,891
Filed 2017-06-28
Tx date 2017-06-28 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+18,500 vol 		201,292
Filed 2017-03-08
Tx date 2017-03-07 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+92,408 vol 		377,737
Filed 2017-01-04
Tx date 2017-01-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash 		$-462,328.20
-81,828 vol
$5.65 each 		56,572
Filed 2017-01-04
Tx date 2017-01-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
-17,193 vol 		56,572
Filed 2017-01-04
Tx date 2017-01-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash 		$-76,269.30
-64,635 vol
$1.18 each 		73,765
Filed 2016-03-24
Tx date 2016-03-23 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+102,537 vol 		285,329
Filed 2016-03-14
Tx date 2013-10-30 		$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+169,807 vol 		169,807
Filed 2016-03-14
Tx date 2013-10-30 		$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
56 - Grant of rights
+169,447 vol
Filed 2016-03-14
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report 		138,400
Filed 2016-03-14
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
-43,882 vol 		0
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
-57,072 vol 		43,882
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
+57,072 vol 		155,786
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report 		138,040
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		182,792
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		155,786
Filed 2016-02-29
Tx date 2016-02-29 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
97 - Other
-7 vol 		182,792
Filed 2016-01-06
Tx date 2016-01-01 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash 		$-426,323.88
-81,828 vol
$5.21 each 		138,040
Filed 2015-12-11
Tx date 2015-12-09 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
-10,929 vol 		0
Filed 2015-12-11
Tx date 2015-12-09 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$32,787
+10,929 vol
$3.00 each 		98,714
Filed 2015-09-24
Tx date 2015-09-21 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-399,997
-30,769 vol
$13.00 each 		182,799
Filed 2015-06-10
Tx date 2015-06-10 		$NRI
Nuvo Research Inc. 		London, John
4 - Director of Issuer
Direct Ownership
Common Shares
99 - Correction of information
-1 vol 		87,785